The share market generally tends to be more concerned with 'return on assets' rather than simply 'assets'. That's not to say that the market is right; but that's how it thinks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025